Assertio therapeutics announces third-quarter 2019 results

Assertio therapeutics announces third-quarter 2019 results.assertio therapeutics inc - company implements new cost savings initiatives expected to deliver annualized savings of $20.0 million.assertio therapeutics inc - raises full-year 2019 earnings guidance ranges.assertio therapeutics inc - lowers full-year 2019 neurology franchise net sales guidance.assertio therapeutics inc - qtrly total revenues $55.1 million.assertio therapeutics inc - qtrly earnings per share $0.05.assertio therapeutics inc - sees 2019 neurology franchise net sales $102 million to $105 million.
ASRT Ratings Summary
ASRT Quant Ranking